Investing Profile

Eric Anschutz


Experienced angel with biotech focus. Selective deal flow supported by quantitative evaluation system. Proven, exit-driven results over 15+ years. Bike lover. Francisco, California
Photo of Eric Anschutz

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
$10K - $250K
CompanyStageDateRound SizeTotal Raised
Attivare Therapeutics
SeedJun 2021$1
Co-investors: Maximilian Winter (Harmonix Fund)
Seed RoundFeb 2021$6M
Primordial Genetics
Seed RoundFeb 2021$1
Seed RoundAug 2020$2.5M
Co-investors: Jordan Fliegel (Techstars)
Seed RoundMay 2019$4.5M
Seed RoundFeb 2017
Co-investors: Phil Libin (General Catalyst), Nate Dalton (Daybreak Partners)
Venture RoundOct 2018
SeedMar 2018$1
Co-investors: Arvind Gupta (Mayfield), Seth Berman (Susa Ventures), Po Bronson (SOSV)
Notable Labs
Series BSep 2017$14.8M
Co-investors: Charlie Pinto (Bling Capital), Ross Blankenship (Angel Kings), Kevin Mahaffey (SNR), Jim Kim (formation|8), Stefano Bernardi
Twist Bioscience
Series DMar 2017$33M
Series DJan 2016$61M
Co-investors: Omri Amirav Drory (NFX), Boris Nikolic (Biomatics Capital Partners), Gibb Witham (Paladin Capital), rich simoni
Biotech, Synthetic Biology, Bicycles, Medical Bioinformatics, Genomics, Genetic Testing, Biotechnology, DNA/RNA, Microbiome, Quantified Self, Medical Devices, Internet of Things, Pharmaceuticals, Bio-Pharma